Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004623325 | SCV005116321 | uncertain significance | not specified | 2024-04-01 | criteria provided, single submitter | clinical testing | The c.413G>T (p.G138V) alteration is located in exon 4 (coding exon 3) of the FGGY gene. This alteration results from a G to T substitution at nucleotide position 413, causing the glycine (G) at amino acid position 138 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |